Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Enrolling By Invitation NCT04693663

Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile

Conditions: Pseudophakia, Myopia

Sex: All

Ages: 20 Years – 70 Years

Healthy volunteers: No

Phase: NA

Enrollment: 20

Sponsor: Eye Hospital Pristina Kosovo

Location: Eye Hospital Pristina Pristina

Summary

The aim of this study is to assess visual and refractive outcomes after laser vision correction (LVC) - ReLex Smile to correct residual myopic refraction after 6 months of pseudophakic (IOL) implantation. Before SMILE YAG-Laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, in pseudophakic patients with residual refraction. When the YAG Laser is applied after the SMILE, there will be a diopter change.

Eligibility Criteria

Inclusion Criteria: * residual myopic refraction -0.75d till -5.50D * complain visual acuity regarding residual myopic refraction Exclusion Criteria: * active anterior segment pathologic features * previous corneal or anterior segment surgery * glaucoma * history of ocular inflammation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04693663). StuddyBuddy aggregates publicly available trial information.